Seattle Genetics Inc. (SGEN) reported a second quarter net loss of $0.15 per share after the close Wednesday, compared to the loss of $0.45 per share last year. The consensus estimate was for a loss of $0.15. The stock is now down 1.85 on 8K shares.
Seattle Genetics declined until mid-morning Wednesday and finished down by 0.47 at $23.87. The stock has been pulling back from the highs of the year for the last week and a half and set nearly a 2-month low.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.